Iain Stuart
Chief Tech/Sci/R&D Officer chez VYNE THERAPEUTICS INC.
Fortune : 410 585 $ au 31/03/2024
Provenance du réseau au premier degré de Iain Stuart
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
VYNE Pharmaceuticals Ltd.
 VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.
16
| Subsidiary | Pharmaceuticals: Major | 16 |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ.
8
| Subsidiary | Drugstore Chains | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Iain Stuart via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PAR PHARMACEUTICAL COMPANIES, INC. | Pharmaceuticals: Generic | Chairman | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| GIVEN IMAGING LTD. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
Warner Chilcott Co., Inc.
 Warner Chilcott Co., Inc. Pharmaceuticals: MajorHealth Technology Warner Chilcott Co., Inc. develops, manufactures and markets branded prescription pharmaceutical products. The company is located in Rockaway, NJ | Pharmaceuticals: Major | Human Resources Officer General Counsel | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INTERSECT ENT, INC. | Medical/Nursing Services | Director/Board Member | |
| PROCEPT BIOROBOTICS CORPORATION | Medical Specialties | Director/Board Member | |
DenX Medical Software Systems Ltd.
 DenX Medical Software Systems Ltd. Medical SpecialtiesHealth Technology DenX Ltd. is engaged in manufacturing of dental equipment. The firm develops and markets image guided technology for dental training and clinical implementation. The company was founded by Hayka Alon in 1994 and is headquartered in Jerusalem, Israel. | Medical Specialties | Chairman | |
Yissum Research Development Co. Ltd.
 Yissum Research Development Co. Ltd. Investment ManagersFinance Yissum Research Development Co. Ltd. (Yissum Research) is a venture capital subsidiary of The Hebrew University of Jerusalem founded in 1964. The firm is headquartered in Jerusalem, Israel. | Investment Managers | Chairman | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree | |
| Syracuse University | College/University | Undergraduate Degree Undergraduate Degree | |
| Loyola University of Chicago | College/University | Undergraduate Degree | |
| Pepperdine University | College/University | Masters Business Admin | |
| Rider University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Irvine | College/University | Undergraduate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Cape Town | College/University | Undergraduate Degree Doctorate Degree | |
| Technion-Israel Institute of Technology | College/University | Graduate Degree | |
| The Hebrew University of Jerusalem | College/University | Doctorate Degree Doctorate Degree | |
TransPharma Medical Ltd.
 TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | Pharmaceuticals: Major | Director/Board Member | |
Warner Chilcott, Inc.
 Warner Chilcott, Inc. Pharmaceuticals: MajorHealth Technology Warner Chilcott, Inc. develops and manufactures drugs. It makes women's health care and urology prescription drugs, dermatology and cardiology drugs. The company is headquartered in Rockaway, NJ. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| BIOLINERX LTD. | Pharmaceuticals: Major | Chairman | |
| PROTALIX BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
American Academy of Dermatology
 American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services American Academy of Dermatology is the largest and most influential dermatology group in the United States. The private company is based in the United States and has subsidiaries in various locations. The American company provides resources on membership, education, practice management, publications, and clinical care for dermatologists. The company also offers information for patients and the public on skin, hair, and nail conditions. Elizabeth Usher has been the CEO of the company since 2019. | Miscellaneous Commercial Services | President Corporate Officer/Principal | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Biotechnology | Chairman | |
Olam Americas, Inc.
 Olam Americas, Inc. Agricultural Commodities/MillingProcess Industries Part of Olam US Holdings, Inc., Olam Americas, Inc. is a private company that provides crop preparation services. Olam Americas, Inc. is based in Summit, NJ. | Agricultural Commodities/Milling | Human Resources Officer Human Resources Officer | |
| ALLERGAN PLC | Pharmaceuticals: Major | Sales & Marketing | |
Bausch & Lomb BV
 Bausch & Lomb BV Electronic ComponentsElectronic Technology Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life. It offers the world's most comprehensive portfolio of eye health products and the proud that it is one of the oldest, best known and most respected healthcare brands in the world. The company began in 1853 in Rochester, New York, as a small optical shop that grew to become a multi-billion dollar corporation with nearly 14,000 employees worldwide, and with products available in more than 100 countries. | Electronic Components | Sales & Marketing | |
BioMAS Ltd.
 BioMAS Ltd. Pharmaceuticals: MajorHealth Technology BioMAS Ltd. is an Israeli pharmaceutical company that was founded in 2000. The private company is based in Jerusalem, Israel and develops drugs that are based on tellurium. | Pharmaceuticals: Major | Chairman | |
| Amorphical Ltd. | Chairman | ||
FlexiProbe Ltd.
 FlexiProbe Ltd. Medical SpecialtiesHealth Technology FlexiProbe Ltd. manufactures medical devices. The private company is based in Ramat-Gan, Israel. The Israeli company was founded in 2001 by Meir Eini, Dov Tamarkin. | Medical Specialties | Founder Chief Executive Officer | |
| Quinlan School of Business | College/University | Masters Business Admin | |
VYNE Pharmaceuticals, Inc.
 VYNE Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals, Inc. manufactures pharmaceutical products. The company was founded on May 6th, 2014 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
ALASTIN Skincare, Inc.
 ALASTIN Skincare, Inc. Household/Personal CareConsumer Non-Durables Alastin Skincare, Inc. develops and markets skin care products that reinvigorate, protect, and maintain healthy skin. It offers skin procedures such as injectables, laser resurfacing, microneedling, peels, photo rejuvination, radio frequency, skin tightening, surgical procedures, and ultra sound therapy. The company was founded by Scott L. Glenn and Cam L. Garner in 2015 and is headquartered in Carlsbad, CA. | Household/Personal Care | Director/Board Member | |
| SATSUMA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Timber Pharmaceuticals LLC
 Timber Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Timber Pharmaceuticals LLC engages in the provision of biopharmaceutical services. It offers congenital ichthyosis, tuberous sclerosis complex, and localized scleroderma. The company was founded in 2019 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Biotechnology | Corporate Officer/Principal | |
| TREX WIND-DOWN, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| MATRICELF LTD | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 32 |
| Israël | 15 |
| Danemark | 2 |
| Afrique du Sud | 2 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 32 |
| Consumer Services | 11 |
| Electronic Technology | 3 |
| Health Services | 2 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 112 |
| Corporate Officer/Principal | 57 |
| Independent Dir/Board Member | 39 |
| Chairman | 30 |
| Chief Executive Officer | 29 |
Relations les plus connectées
| Insiders | |
|---|---|
| Aharon Schwartz | 29 |
| Rex Bright | 24 |
| Stanley Stern | 23 |
| Steven Basta | 19 |
| Dalia Megiddo | 18 |
| Pat LePore | 15 |
| Darrell S. Rigel | 13 |
| Andrew Saik | 12 |
| Elisabeth Sandoval | 12 |
| Sharon Barbari | 12 |
| Anthony Bruno | 11 |
| Stanley Hirsch | 11 |
| Xiaoming Zhang | 11 |
| John Koconis | 10 |
| Anna Kazanchyan | 9 |
- Bourse
- Insiders
- Iain Stuart
- Connexions Sociétés
